Press
SATT Nord is leading an academic partnership in collaboration with Boehringer Ingelheim to develop a new treatment for people with pulmonary fibrosis.
Read more
Success stories, testimonials from our investors, and startup news.
Don't miss out on the latest news from Satt Nord!
Read more
Read more
Read more
Read more
Read more
Read more